Open House Biologics Discount Agreements 2024-03 - Omalizumab

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 81713392

  Document Type - Tender Notices

Description - Description: The participating health insurance companies pursue the goal of concluding discount agreements with all suitable pharmaceutical companies in accordance with Section 130a Paragraph 8 SGB V for the active ingredient Omalizumab. The contrac t is concluded as part of the open house biologics procedure of the participating health insurance companies: individual negotiations about contract contents are not conducted; uniform conditions apply. The health insurance companies involved do not guarantee individual contractual partners any exclusivity. The contract term is a maximum of 24 months starting on July 1st, 2024. The contract ends on June 30, 2026 at the latest, regardless of the d

Gt Ref Id - 81713392

Deadline - Jun 30, 2026